Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Barna, M., Pusic, A., Zollo, O., Costa, M., Kondrashov, N., Rego, E., Rao, P. H., & Ruggero, D. (2008). Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature, 456(7224), 971–975.

Authors 8
  1. Maria Barna (first)
  2. Aya Pusic (additional)
  3. Ornella Zollo (additional)
  4. Maria Costa (additional)
  5. Nadya Kondrashov (additional)
  6. Eduardo Rego (additional)
  7. Pulivarthi H. Rao (additional)
  8. Davide Ruggero (additional)
References 35 Referenced 386
  1. Gomez-Roman, N. et al. Activation by c-Myc of transcription by RNA polymerases I, II and III. Biochem. Soc. Symp. 73, 141–154 (2006) (10.1042/bss0730141) / Biochem. Soc. Symp. by N Gomez-Roman (2006)
  2. Ruggero, D. & Pandolfi, P. P. Does the ribosome translate cancer? Nature Rev. Cancer 3, 179–192 (2003) (10.1038/nrc1015) / Nature Rev. Cancer by D Ruggero (2003)
  3. Cornelis, S. et al. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell 5, 597–605 (2000) (10.1016/S1097-2765(00)80239-7) / Mol. Cell by S Cornelis (2000)
  4. Petretti, C. et al. The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep. 7, 418–424 (2006) (10.1038/sj.embor.7400639) / EMBO Rep. by C Petretti (2006)
  5. Wilker, E. W. et al. 14-3-3σ controls mitotic translation to facilitate cytokinesis. Nature 446, 329–332 (2007) (10.1038/nature05584) / Nature by EW Wilker (2007)
  6. Boxer, L. M. & Dang, C. V. Translocations involving c-myc and c-myc function. Oncogene 20, 5595–5610 (2001) (10.1038/sj.onc.1204595) / Oncogene by LM Boxer (2001)
  7. Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nature Rev. Cancer 2, 764–776 (2002) (10.1038/nrc904) / Nature Rev. Cancer by S Pelengaris (2002)
  8. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N. & Edgar, B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nature Cell Biol. 7, 295–302 (2005) (10.1038/ncb1223) / Nature Cell Biol. by SS Grewal (2005)
  9. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779–790 (1999) (10.1016/S0092-8674(00)81512-3) / Cell by LA Johnston (1999)
  10. Moreno, E. & Basler, K. dMyc transforms cells into super-competitors. Cell 117, 117–129 (2004) (10.1016/S0092-8674(04)00262-4) / Cell by E Moreno (2004)
  11. de la Cova, C., Abril, M., Bellosta, P., Gallant, P. & Johnston, L. A. Drosophila myc regulates organ size by inducing cell competition. Cell 117, 107–116 (2004) (10.1016/S0092-8674(04)00214-4) / Cell by C de la Cova (2004)
  12. Oliver, E. R., Saunders, T. L., Tarle, S. A. & Glaser, T. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute . Development 131, 3907–3920 (2004) (10.1242/dev.01268) / Development by ER Oliver (2004)
  13. Harris, A. W. et al. The Eμ-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167, 353–371 (1988) (10.1084/jem.167.2.353) / J. Exp. Med. by AW Harris (1988)
  14. Iritani, B. M. & Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci. USA 96, 13180–13185 (1999) (10.1073/pnas.96.23.13180) / Proc. Natl Acad. Sci. USA by BM Iritani (1999)
  15. Thomas, G. An encore for ribosome biogenesis in the control of cell proliferation. Nature Cell Biol. 2, E71–E72 (2000) (10.1038/35010581) / Nature Cell Biol. by G Thomas (2000)
  16. Yang, W. et al. Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688–1702 (2001) (10.1038/sj.onc.1204245) / Oncogene by W Yang (2001)
  17. Wu, S. et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351–360 (2003) (10.1038/sj.onc.1206145) / Oncogene by S Wu (2003)
  18. Bouchard, C. et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321–5333 (1999) (10.1093/emboj/18.19.5321) / EMBO J. by C Bouchard (1999)
  19. Pyronnet, S. & Sonenberg, N. Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11, 13–18 (2001) (10.1016/S0959-437X(00)00150-7) / Curr. Opin. Genet. Dev. by S Pyronnet (2001)
  20. Hellen, C. U. & Sarnow, P. Internal ribosome entry sites in eukaryotic mRNAmolecules. Genes Dev. 15, 1593–1612 (2001) (10.1101/gad.891101) / Genes Dev. by CU Hellen (2001)
  21. Dave, B. J. et al. Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet. Cytogenet. 108, 120–126 (1999) (10.1016/S0165-4608(98)00138-1) / Cancer Genet. Cytogenet. by BJ Dave (1999)
  22. Nelson, M. A. et al. Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet. Cytogenet. 108, 91–99 (1999) (10.1016/S0165-4608(98)00122-8) / Cancer Genet. Cytogenet. by MA Nelson (1999)
  23. Lahti, J. M. et al. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet. 7, 370–375 (1994) (10.1038/ng0794-370) / Nature Genet. by JM Lahti (1994)
  24. Chandramouli, A. et al. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Carcinogenesis 28, 2028–2035 (2007) (10.1093/carcin/bgm066) / Carcinogenesis by A Chandramouli (2007)
  25. Fujiwara, T. et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043–1047 (2005) (10.1038/nature04217) / Nature by T Fujiwara (2005)
  26. Wade, M. & Wahl, G. M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr. Top. Microbiol. Immunol. 302, 169–203 (2006) / Curr. Top. Microbiol. Immunol. by M Wade (2006)
  27. Amsterdam, A. et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2, e139 (2004) (10.1371/journal.pbio.0020139) / PLoS Biol. by A Amsterdam (2004)
  28. Ganem, N. J., Storchova, Z. & Pellman, D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157–162 (2007) (10.1016/j.gde.2007.02.011) / Curr. Opin. Genet. Dev. by NJ Ganem (2007)
  29. Svitkin, Y. V. et al. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell. Biol. 25, 10556–10565 (2005) (10.1128/MCB.25.23.10556-10565.2005) / Mol. Cell. Biol. by YV Svitkin (2005)
  30. Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006) (10.1126/science.1123835) / Science by A Yoon (2006)
  31. Ruggero, D. L. et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Med. 10, 484–486 (2004) (10.1038/nm1042) / Nature Med. by DL Ruggero (2004)
  32. Lenahan, M. K. & Ozer, H. L. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts. Oncogene 12, 1847–1854 (1996) / Oncogene by MK Lenahan (1996)
  33. Ferguson, A. M., White, L. S., Donovan, P. J. & Piwnica-Worms, H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol. Cell Biol. 25, 2853–2860 (2005) (10.1128/MCB.25.7.2853-2860.2005) / Mol. Cell Biol. by AM Ferguson (2005)
  34. Beretta, L., Gingras, A. C., Svitkin Y.V, M. N. & Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. Embo J. 15, 658–664 (1996) (10.1002/j.1460-2075.1996.tb00398.x) / Embo J. by L Beretta (1996)
  35. Kallioniemi, O. P. et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom. Cancer 10, 231–243 (1994) (10.1002/gcc.2870100403) / Genes Chromosom. Cancer by OP Kallioniemi (1994)
Dates
Type When
Created 16 years, 9 months ago (Nov. 16, 2008, 1:04 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 2:20 p.m.)
Indexed 44 minutes ago (Sept. 4, 2025, 10:18 a.m.)
Issued 16 years, 9 months ago (Nov. 16, 2008)
Published 16 years, 9 months ago (Nov. 16, 2008)
Published Online 16 years, 9 months ago (Nov. 16, 2008)
Published Print 16 years, 9 months ago (Dec. 1, 2008)
Funders 0

None

@article{Barna_2008, title={Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency}, volume={456}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature07449}, DOI={10.1038/nature07449}, number={7224}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Barna, Maria and Pusic, Aya and Zollo, Ornella and Costa, Maria and Kondrashov, Nadya and Rego, Eduardo and Rao, Pulivarthi H. and Ruggero, Davide}, year={2008}, month=nov, pages={971–975} }